| pubmed-article:21204911 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21204911 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21204911 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:21204911 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
| pubmed-article:21204911 | lifeskim:mentions | umls-concept:C0360714 | lld:lifeskim |
| pubmed-article:21204911 | lifeskim:mentions | umls-concept:C0441471 | lld:lifeskim |
| pubmed-article:21204911 | lifeskim:mentions | umls-concept:C0011847 | lld:lifeskim |
| pubmed-article:21204911 | lifeskim:mentions | umls-concept:C1510802 | lld:lifeskim |
| pubmed-article:21204911 | lifeskim:mentions | umls-concept:C0027775 | lld:lifeskim |
| pubmed-article:21204911 | lifeskim:mentions | umls-concept:C0205164 | lld:lifeskim |
| pubmed-article:21204911 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:21204911 | pubmed:dateCreated | 2011-4-12 | lld:pubmed |
| pubmed-article:21204911 | pubmed:abstractText | To evaluate whether good statin adherence is associated with a reduced incidence of major coronary events (MCEs) among diabetic patients with and without coronary heart disease (CHD). | lld:pubmed |
| pubmed-article:21204911 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21204911 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21204911 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21204911 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21204911 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21204911 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21204911 | pubmed:month | May | lld:pubmed |
| pubmed-article:21204911 | pubmed:issn | 1365-2125 | lld:pubmed |
| pubmed-article:21204911 | pubmed:author | pubmed-author:JulaAnttiA | lld:pubmed |
| pubmed-article:21204911 | pubmed:author | pubmed-author:HuupponenRist... | lld:pubmed |
| pubmed-article:21204911 | pubmed:author | pubmed-author:KettunenRaimo... | lld:pubmed |
| pubmed-article:21204911 | pubmed:author | pubmed-author:Helin-Salmiva... | lld:pubmed |
| pubmed-article:21204911 | pubmed:author | pubmed-author:KorhonenMaari... | lld:pubmed |
| pubmed-article:21204911 | pubmed:author | pubmed-author:RuokoniemiPäi... | lld:pubmed |
| pubmed-article:21204911 | pubmed:author | pubmed-author:LavikainenPii... | lld:pubmed |
| pubmed-article:21204911 | pubmed:author | pubmed-author:JunnilaSeppo... | lld:pubmed |
| pubmed-article:21204911 | pubmed:copyrightInfo | © 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society. | lld:pubmed |
| pubmed-article:21204911 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21204911 | pubmed:volume | 71 | lld:pubmed |
| pubmed-article:21204911 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21204911 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21204911 | pubmed:pagination | 766-76 | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:meshHeading | pubmed-meshheading:21204911... | lld:pubmed |
| pubmed-article:21204911 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21204911 | pubmed:articleTitle | Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study. | lld:pubmed |
| pubmed-article:21204911 | pubmed:affiliation | Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland. | lld:pubmed |
| pubmed-article:21204911 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21204911 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
